浙江三生蔓迪药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
76
NMPA:76
Drug Approvals
Ubidecarenone Injection
- Product Name
- 辅酶Q10注射液
- Approval Number
- 国药准字H33020904
- Approval Date
- Sep 13, 2024
NMPA
Rosiglitazone Hydrochloride Tablets
- Product Name
- 宜力喜
- Approval Number
- 国药准字H20041409
- Approval Date
- Sep 6, 2024
NMPA
Polyinosinic-Polycytidylic Acid Injection
- Product Name
- 聚肌胞注射液
- Approval Number
- 国药准字H20003550
- Approval Date
- Sep 5, 2024
NMPA
Rosiglitazone Hydrochloride Tablets
- Product Name
- 宜力喜
- Approval Number
- 国药准字H20041408
- Approval Date
- Sep 5, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
No trials found
News
No news found